Haleon PLC Sponsored ADR

HLN Healthcare Drug Manufacturers Specialty & Generic

Haleon PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $14.5 billion, up 1.33% from fiscal 2024. Revenue growth for three consecutive years, operating cash flow growth for three.

10.13 0.19 +1.91%
Market cap
$43.7B
P/E
22.6×
Fwd P/E
17.6×
Dividend yield
1.95%
F-score
8/9
Altman Z
3.04
Beneish M
−2.60
Dividend safety
66/100

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Jun '23 Jun '24 Jun '25 Jun '26
Total current assets
5,261.32 5,944.49 5,534.73 5,758.95
Total non-current assets
37,515.43 36,204.60 36,974.75 37,968.01
Total Assets
42,776.75 42,149.09 42,509.48 43,726.96
Total current liabilities
6,244.22 7,098.05 6,362.80 8,380.07
Total non-current liabilities
15,788.98 13,965.14 14,779.75 13,282.76
Total liabilities
22,033.20 21,063.19 21,142.55 21,662.84
Common Equity (Total)
20,743.54 21,085.91 21,366.93 22,064.12
Shareholders Equity (Total)
20,743.54 21,085.90 21,366.93 22,064.12
Total Debt
12,351.96 11,179.68 11,324.55 11,075.01

Show all line items

In millions of $ except per-share values · columns are period end dates